# Specified Drug-use Survey of Fomepizole Intravenous Infusion (All-case Surveillance)

> **NCT02415712** · — · COMPLETED · sponsor: **Takeda** · enrollment: 147 (actual)

## Conditions studied

- Ethylene Glycol Poisoning, Methanol Poisoning

## Interventions

- **DRUG:** Fomepizole

## Key facts

- **NCT ID:** NCT02415712
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-27
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2024-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02415712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02415712, "Specified Drug-use Survey of Fomepizole Intravenous Infusion (All-case Surveillance)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02415712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*